참고문헌
- Nijweidi Peter, J., JEAN, H., M. FEYEN. "Cells of Bone: Proliferation, Differentiation, and Hormonal Regulation". Physiological Reviews. 66(4):855-886, 1986.
- Rodan, G.A., Martin, T.J. Therapeutic approaches to bone diseases. Science. 289: 1508-1514, 2000. https://doi.org/10.1126/science.289.5484.1508
- Teitelbaum, S.L., Ross, F.P. Genetic regulation of osteoclast development and function. Nat. Rev. Genat. 4: 638-649, 2003. https://doi.org/10.1038/nrg1122
- Boyle, W.J., Simonet W.S., Lacey D.L., Osteoclast differentiation and activation. Nature. 423: 337-342, 2003. https://doi.org/10.1038/nature01658
- Takayanagi, H. Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat. Rev. Immunol. 7: 292-304, 2007. https://doi.org/10.1038/nri2062
- Lee, Z.H., Kim, H.H. Signal transduction by receptor activator of nuclear factor kappa B in osteoclasts. Biochem. Biophys. Res. Commun. 305: 211-214, 2003. https://doi.org/10.1016/S0006-291X(03)00695-8
- Takayanagi, H., Kim, S., Koga, T., Nishina, H., Isshiki, M., Yoshida, H., Saiura, A., Isobe, M., Yokochi, T., Inoue, J., Wagner, E.F., Mak, T.W., Kodama, T., Taniguchi, T. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev. Cell. 23: 889-901, 2000.
- J.C. Jeong, B.T. Lee, and C.H. Yoon, Effects of Drynariae Rhizoma on the proliferation of human bone cells and the immunomodulatory activity, Pharmacological Research. 51(2):125-136, 2005. https://doi.org/10.1016/j.phrs.2004.06.005
- Hong, S.N., Jeong, J.C. Effects of complex extracts having Drynariae Rhizoma on suppression of collagenolysis and bone resorption in mouse calvarial osteoblasts. D.J.I.O.M. 9: 179-191, 2000.
- Takayanagi, H. Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat. Rev. Immunol. 7: 292-304, 2007. https://doi.org/10.1038/nri2062
- M.L. Scott, T. Fujita, H.C. Liou. The p65 subunit of NF-kappa B regulates I kappa B by two distinct mechanisms. Genes Dev. 1993; 7: 1266-1276, 1993. https://doi.org/10.1101/gad.7.7a.1266
- Kanis, J.A., Oden, A., Johnell, O., De Laet, C., Jonsson, B., Oglesby, A.K. The components of excess mortality after hip fracture. Bone. 32: 468, 2003. https://doi.org/10.1016/S8756-3282(03)00061-9
- Abrahamsen, B. Adverse effects of bisphosphonates. CalcifTissue Int. 86(60):421-435, 2010.
- Jimi, E., Aoki, K., Saito, H., D'Acpuisto, F., May, M.J., Nakamura, I., Sudo, T., Kojima T., Okamoto, Fukushima, H., Okabe, K., Ohya, K., Ghosh, S. Selective inhibition of NF-kappa B blocks osteoclastogenesis and prevents inflammatory bone destrution in vivo. Nat. Med. 10: 617-624, 2004. https://doi.org/10.1038/nm1054
- Lin, L., DeMartino, G.N., Greene, W.C. Cotranslational biogenesis of NF-kappaB p50 by the 26S proteasome. Cell. 92: 819-828, 1998. https://doi.org/10.1016/S0092-8674(00)81409-9